Shopping Cart
- Remove All
Your shopping cart is currently empty
Norswertianolin, a compound isolated from G. acuta, is a small molecule activator of CSE, which enhances the H-generation 2S activity of CSE and can be used in the study of cardiovascular diseases.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $147 | In Stock | |
| 5 mg | $378 | In Stock | |
| 10 mg | $612 | In Stock | |
| 25 mg | $953 | In Stock | |
| 50 mg | $1,280 | In Stock |
| Description | Norswertianolin, a compound isolated from G. acuta, is a small molecule activator of CSE, which enhances the H-generation 2S activity of CSE and can be used in the study of cardiovascular diseases. |
| In vitro | Norswertianolin (3.125-50 μM) was able to protect against H2O2-induced damage in H9c2 cells. In addition, Norswertianolin significantly increased the transcript levels of HO-1 and GCLC in H9c2 cells. [1] In HepG2 cells, high concentrations of Norswertianolin (0~150 μM) were able to increase the expression level of CSE protein. [2] |
| In vivo | Animal experiments showed that Norswertianolin (4.4 mg/kg/day, subcutaneous injection for one week) improved CSE/H₂S production and attenuated renal tubular injury induced by acute ischemia/reperfusion, and exerted antioxidant effects by decreasing ROS levels. In addition, it has antihypertensive, inhibits vascular remodeling and reduces inflammation. [2] |
| Molecular Weight | 422.34 |
| Formula | C19H18O11 |
| Cas No. | 54954-12-0 |
| Smiles | O(C1=C2C(OC=3C(C2=O)=C(O)C=C(O)C3)=C(O)C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O |
| Color | Yellow |
| Appearance | Solid |
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (47.36 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.74 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.